Steven Cohen’s Pacific Biosciences PACB Stock Holding History

Steven Cohen’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.04M	Buy	4,787,300 +4,501,600	+1,576%	+$6.54M	0.01%	1422
2026 Q1	$377K	Sell	285,700 -2,671,700	-90%	-$4.78M	﹤0.01%	3262
2025 Q4	$5.53M	Buy	+2,957,400	New	+$5.68M	0.01%	1772
2025 Q3	–	Sell	-914,190	Closed	-$1.13M	–	2591
2025 Q2	$1.13M	Buy	+914,190	New	+$1.06M	﹤0.01%	1511
2024 Q1	–	Sell	-5,349,146	Closed	-$31.3M	–	2511
2023 Q4	$52.5M	Buy	5,349,146 +2,755,364	+106%	+$22.5M	0.13%	204
2023 Q3	$21.7M	Sell	2,593,782 -4,067,851	-61%	-$46.5M	0.06%	390
2023 Q2	$88.6M	Sell	6,661,633 -627,735	-9%	-$7.63M	0.26%	91
2023 Q1	$84.4M	Buy	7,289,368 +1,957,373	+37%	+$19.5M	0.26%	90
2022 Q4	$43.6M	Buy	5,331,995 +2,797,889	+110%	+$24.1M	0.15%	184
2022 Q3	$14.7M	Buy	+2,534,106	New	+$14.5M	0.06%	403
2021 Q1	–	Sell	-40,000	Closed	-$1.04M	–	1123
2020 Q4	$1.04M	Sell	40,000 -2,271,631	-98%	-$38.6M	0.01%	804
2020 Q3	$22.8M	Buy	+2,311,631	New	+$13.3M	0.12%	242
2018 Q4	–	Sell	-5,175,000	Closed	-$28M	–	1150
2018 Q3	$28M	Buy	5,175,000 +2,275,000	+78%	+$9.76M	0.12%	227
2018 Q2	$10.3M	Buy	2,900,000 +800,000	+38%	+$2.22M	0.04%	437
2018 Q1	$4.3M	Buy	+2,100,000	New	+$5.45M	0.02%	609
2017 Q2	–	Sell	-1,279,200	Closed	-$6.61M	–	958
2017 Q1	$6.61M	Buy	+1,279,200	New	+$6.26M	0.04%	477
2016 Q2	–	Sell	-706,500	Closed	-$6M	–	837
2016 Q1	$6M	Buy	706,500 +700,300	+11,295%	+$6.89M	0.05%	401
2015 Q4	$81K	Sell	6,200 -10,900	-64%	-$97.8K	﹤0.01%	655
2015 Q3	$63K	Buy	17,100 +17,000	+17,000%	+$83.1K	﹤0.01%	716
2015 Q2	$1K	Buy	+100	New	+$579	﹤0.01%	702

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Steven Cohen's PACB Position: Q2 2026 in Review

Steven Cohen increased its Pacific Biosciences (PACB) stake by 1,576% in Q2 2026, buying an estimated $6.54M and bringing the position to 4,787,300 shares worth $8.04M. The position accounts for 0.01% of the portfolio, ranked #1422.

Steven Cohen first reported a position in PACB in Q2 2015 and has held it in 20 quarters since. The position peaked at $88.6M in Q2 2023. 222 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Steven Cohen held 4,787,300 shares of Pacific Biosciences worth $8.04M as of Q2 2026.
Steven Cohen bought 4,501,600 Pacific Biosciences shares in Q2 2026, an estimated $6.54M.
Pacific Biosciences made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1422 holding.
Steven Cohen first reported a position in Pacific Biosciences in Q2 2015 and has held it in 20 quarters since.
Steven Cohen's Pacific Biosciences position peaked at $88.6M in Q2 2023.
222 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.